Selenofolate inhibits the proliferation of IGROV1 cancer cells independently from folate receptor alpha

Cancer is one of the main causes of human mortality worldwide and novel chemotherapeutics are required due to the limitations of conventional cancer therapies. For example, using redox selenium compounds as novel chemotherapeutics seem to be very promising. The objective of this study was to explore...

Full description

Bibliographic Details

Published in:	Heliyon
Main Authors:	Ali Razaghi, Antje Maria Zickler, Julian Spallholz, Gilbert Kirsch, Mikael Björnstedt
Format:	Article
Language:	English
Published:	Elsevier 2021-06-01
Subjects:	Folate Selenofolate Folate receptor Cancer Selenotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844021013578